News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
221 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21247)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
1 (203)
2 (149)
3 (152)
4 (94)
7 (175)
8 (168)
9 (149)
10 (127)
11 (110)
14 (164)
15 (221)
16 (187)
17 (179)
18 (112)
21 (151)
22 (166)
23 (154)
24 (153)
25 (147)
28 (142)
29 (167)
30 (191)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
7
8
9
10
11
14
15
16
17
18
21
22
23
24
25
28
29
30
Drug Development
MS&L Release: Study Shows that High-Dose, High-Frequency Interferon Produces no Additional Benefit on Efficacy Compared to AVONEX(R) (interferon beta-1a) in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
April 15, 2008
·
1 min read
Drug Development
Peregrine Pharmaceuticals, Inc. Data Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
April 15, 2008
·
7 min read
Drug Development
Novelos Therapeutics, Inc. and Medical University of South Carolina Peer Reviewed Article Published in Cancer Research
April 15, 2008
·
1 min read
Drug Development
IOMAI Corporation Receives Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
April 15, 2008
·
5 min read
Pharm Country
Heritage Pharmaceuticals Announces $10 Million Financing
April 15, 2008
·
2 min read
Genetown
Aileron Therapeutics Completes $10M Financing
April 15, 2008
·
2 min read
Drug Development
Senesco Technologies, Inc. Expands on Recently Announced Preclinical Pancreatic Islet Data
April 15, 2008
·
3 min read
Drug Development
BioMS Medical’s Phase III Multiple Sclerosis Trial Receives Positive Safety Review from Data Safety Monitoring Board
April 15, 2008
·
3 min read
Drug Development
AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia
April 15, 2008
·
5 min read
Drug Development
Pharmacopeia, Inc. Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
April 15, 2008
·
4 min read
Previous
5 of 23
Next
